November 12, 2024 – Talk Bio

Actionable Insights Powered by AI

Pfizer Weighs Sale of Hospital Drugs Unit Amid Activist Pressure

7 months ago talkbio0Tagged activist investor, Goldman Sachs, hospital drugs unit, Pfizer, Sales - occupational activity, Starboard Value

Pfizer, hospital drugs unit, sale, activist investor, Starboard Value, Goldman Sachs

Roche and Flare Therapeutics Launch $1.8B-Plus Cancer Collaboration Targeting Transcription Factors

7 months ago talkbio0Tagged cancer drugs, Collaboration, Flare, Neoplasms, Roche (company), TRANSCRIPTION FACTOR

Roche, Flare Therapeutics, transcription factors, cancer drugs, oncology, biotech collaboration

Bayer’s Q3 Earnings Plummet 37%, CEO Urges Patience Amid Performance-Boosting Strategy

7 months ago talkbio0Tagged Avian crop, Bayer, Bill Anderson, CEO, decline, earnings, generics, Kerendia, Nubeqa, performance-boosting strategy

Bayer, Q3 earnings, decline, CEO Bill Anderson, performance-boosting strategy, pharmaceuticals, crop science, generics, Xarelto, Nubeqa, Kerendia.

ALK-Abell Acquires Epinephrine Nasal Spray for $145 Million

7 months ago talkbio0Tagged Acquisition, ALK-Abell, Dosage Forms, Epinephrine Nasal, portfolio, Spray Dosage Form

ALK-Abell, Epinephrine Nasal Spray, Acquisition, Pharmaceutical Portfolio

IDEAYA Advances Cancer Pipeline with Biocytogen’s Bispecific ADC, Targeting B7H3/PTK7

7 months ago talkbio0Tagged B7H3/PTK7, Biocytogen, bispecific ADC, cancer pipeline, IDEAYA, Precision Medicine, therapeutic autologous dendritic cells

IDEAYA, Biocytogen, Bispecific ADC, B7H3/PTK7, Cancer Pipeline, Precision Medicine Oncology